Press releases
Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients
9th November 2022
Latest news, Events and Press Releases
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
Please direct any media inquiries to Camilla Campbell, VP Communications at camilla.campbell@curiumpharma.com.
Press releases
Press releases
NRG and Curium Sign Multi-Year Isotope Production Contract
18th August 2022
Press releases
Curium Announces The Submission Of Its Marketing Authorization Application For [<sup>18</sup>F]-DCFPyL To The European Medicines Agency
27th June 2022
Press releases
Curium Confirms No Supply Challenges of 177Lu-PSMA-I&T for ECLIPSE Trial
12th May 2022
Press releases
Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
3rd May 2022
Press releases
Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity
19th April 2022
Press releases
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
5th April 2022
Press releases
Curium to become major player in the supply on non carrier added Lu-177
25th January 2022
Press releases
Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer
15th December 2021
Press releases
Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T
27th October 2021
Press releases
Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T
24th August 2021
Press releases
Curium Acquires Austrian Radiopharmaceuticals Company IASON
1st June 2021